Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MALIGNANT PLEURAL MESOTHELIOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT02414945
What this trial is testing

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Who this might be right for
Pleural Mesothelioma
University Health Network, Toronto 9
Large-scale testing (Phase 3)Study completedNCT02991482
What this trial is testing

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 144
Not applicableStudy completedNCT02585362
What this trial is testing

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program

Who this might be right for
Lung CancerGastro-Intestinal CancerBreast Cancer+5 more
Kantonsspital Winterthur KSW 52
Testing effectiveness (Phase 2)Study completedNCT01644994
What this trial is testing

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University of Zurich 47
Not applicableLooking for participantsNCT05538806
What this trial is testing

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

Who this might be right for
Pleural Mesothelioma
NovoCure Ltd. 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT02153229
What this trial is testing

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Who this might be right for
Epitheliod Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 52
Early research (Phase 1)Study completedNCT04040231
What this trial is testing

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Who this might be right for
MesotheliomaPleural MesotheliomaWilms Tumor
Memorial Sloan Kettering Cancer Center 10
Not applicableLooking for participantsNCT06037941
What this trial is testing

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT03762018
What this trial is testing

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 400
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Not applicableLooking for participantsNCT07561190
What this trial is testing

Multidimensional Omics Analysis in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
Azienda USL Reggio Emilia - IRCCS 300
Not applicableUnknownNCT05042557
What this trial is testing

Real World Study of MPM in China

Who this might be right for
Malignant Pleural MesotheliomaDiagnoses DiseaseTreatments+1 more
Chinese Academy of Medical Sciences 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06097728
What this trial is testing

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Who this might be right for
Unresectable Pleural Mesothelioma
AstraZeneca 863
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Ended earlyNCT04166734
What this trial is testing

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant Pleural Mesothelioma
Royal Marsden NHS Foundation Trust 5
Early research (Phase 1)Study completedNCT01212367
What this trial is testing

Intrapleural Gene Transfer for Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 13
Testing effectiveness (Phase 2)Study completedNCT01211275
What this trial is testing

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 32
Next Page